Incidences of other toxicities were comparable across the three treatment groups in DURATION-8 (exenatide plus dapagliflozin, exenatide alone, and dapagliflozin alone, respectively), including pancreatitis (1.3%, 0.4%, and 0%), volume depletion (1.3%, 0.4%, and 2.1%), gastrointestinal events (20.8%, 23.9%, and 16.3%), and genital infections (5.2%, 2.2%, and 7.7%) [36]
S., Lightowler, H., Ahlstrom, L., & Gallagher, A
It affects a significant number of users, and for some, it can be disruptive
Many users also present with hypertension, sleep apnea or other conditions that strengthen the case for structured care
In a study** using 10 g of Fibersol daily, participants experienced: A separate study also shows that Fibersol significantly improves satiety levels, especially during the first 4 hours after a meal